BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19703775)

  • 1. Synthesis and biological evaluation of 4-fluoroproline and 4-fluoropyrrolidine-2-acetic acid derivatives as new GABA uptake inhibitors.
    Zhuang W; Zhao X; Zhao G; Guo L; Lian Y; Zhou J; Fang D
    Bioorg Med Chem; 2009 Sep; 17(18):6540-6. PubMed ID: 19703775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New highly potent GABA uptake inhibitors selective for GAT-1 and GAT-3 derived from (R)- and (S)-proline and homologous pyrrolidine-2-alkanoic acids.
    Fülep GH; Hoesl CE; Höfner G; Wanner KT
    Eur J Med Chem; 2006 Jul; 41(7):809-24. PubMed ID: 16766089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azetidine derivatives as novel gamma-aminobutyric acid uptake inhibitors: synthesis, biological evaluation, and structure-activity relationship.
    Faust MR; Höfner G; Pabel J; Wanner KT
    Eur J Med Chem; 2010 Jun; 45(6):2453-66. PubMed ID: 20219271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of new GABA-uptake inhibitors derived from proline and from pyrrolidine-2-acetic acid.
    Zhao X; Hoesl CE; Hoefner GC; Wanner KT
    Eur J Med Chem; 2005 Mar; 40(3):231-47. PubMed ID: 15725493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs.
    White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A
    J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.
    Kragler A; Höfner G; Wanner KT
    Eur J Med Chem; 2008 Nov; 43(11):2404-11. PubMed ID: 18395300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors.
    Zhao X; Pabel J; Höfner GC; Wanner KT
    Bioorg Med Chem; 2013 Jan; 21(2):470-84. PubMed ID: 23245753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.
    Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B
    Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.
    Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
    J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids.
    Steffan T; Renukappa-Gutke T; Höfner G; Wanner KT
    Bioorg Med Chem; 2015 Mar; 23(6):1284-306. PubMed ID: 25698617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I).
    Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H
    Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists.
    Chiba J; Takayama G; Takashi T; Yokoyama M; Nakayama A; Baldwin JJ; McDonald E; Moriarty KJ; Sarko CR; Saionz KW; Swanson R; Hussain Z; Wong A; Machinaga N
    Bioorg Med Chem; 2006 Apr; 14(8):2725-46. PubMed ID: 16377201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of GABA transporter 3 in GABAergic synaptic transmission at striatal output neurons.
    Kirmse K; Kirischuk S; Grantyn R
    Synapse; 2009 Oct; 63(10):921-9. PubMed ID: 19588470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors.
    Yan L; Budhu R; Huo P; Lynch CL; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Mandala SM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3564-8. PubMed ID: 16621543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
    Quandt G; Höfner G; Wanner KT
    Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides.
    Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J
    J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
    Metzner L; Kalbitz J; Brandsch M
    J Pharmacol Exp Ther; 2004 Apr; 309(1):28-35. PubMed ID: 14718599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of GABA uptake in subcellular fractions of bovine frontal cortex and brainstem.
    Höfner G; Wanner KT
    Neurosci Lett; 2004 Jun; 364(1):53-7. PubMed ID: 15193755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
    Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of new 4,4-diphenylbut-3-enyl derivatives of 4-hydroxybutanamides as GABA uptake inhibitors.
    Kowalczyk P; Höfner G; Wanner KT; Kulig K
    Acta Pol Pharm; 2012; 69(1):157-60. PubMed ID: 22574521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.